(Date:11/20/2009)...ries have an opportunity to take the lead in two s...niversity of Valencia (UV), working together with ...e fabric of the Spanish biotechnology industry. Th...ors have more clout than those in English-speaking...nd plants has been overlooked by the leading count...
(Date:11/20/2009)...vember 20 Karolinska Development A...d (EIF) has entered into a,co-investment agreement...managed by Karolinska Development and used to inve...aceutical and medical technology companies. EIF,ha...nt fund. The agreement,represents EIF,s largest si...
(Date:11/19/2009)... able to charge their cell phones and other person... discovery made by UC San Diego engineers could le...ould do just this. , In recent research, publis...u, a professor in the UCSD Department of Mechanica...tudent Mark Hoefer, have found that artificially i...
(Date:11/19/2009)... Md., Nov. 19 Spherix In...chnology for diabetes therapy, and a provider of t...d, supplement, biotechnology and pharmaceutical co...reported $6.3 million registered direct placement ...its common stock and warrants to purchase up to 1,...
Breaking Biology Technology:Spanish biotechnology should focus on food and plant sectors to be more competitive 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Nanotube defects equal better energy and storage systems 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3...d Notes Achievements over 4-year Period, Progress... Preparing for Challenges of 2008, K...ion (NYSE: SGP ) today reported financial results...mmented on its ongoing integration of,Organon BioS... 2007 and,includes the Organon human health busine...
...ference at the Waldorf-Astoria in New York ... YORK, Feb. 12 BIO CEO & Investor,conference -- J...erapeutics, Inc. (CTI) (Nasdaq: CTIC ; MTAX) will...rketing strategy intended to grow Zevalin(R),(Ibri...s figure reported,for 2007. CTI completed the acqu...
...(Nasdaq: MAXY ), a biotechnology company focused ...y announced that it will present at the Roth,20th ...uary 19, 2008 at,9:00 a.m. Pacific Time. Russell H...ent. A live webcast of the presentation can be acc...com/webcasts . A replay of the,presentation will b...
Other Biology Technology:Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 2Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 3Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 4Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 5Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 6Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 7Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 8Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 9Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 10Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 11Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 12Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 13Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 14Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 15Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 16Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 17Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 18Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 19Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 20Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 21Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 22Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 23Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 24Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 25Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 26Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 27Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 28Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008 2Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008 3Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008 4Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008 5Goat Anti-Human Xg Affinity Purified Polyclonal Antibody, Unconjugated from R&D Systems
Japanese medaka Vitellogenin Standard from Cayman Chemical
Mouse Collagen IV, Unconjugated from R&D Systems
Captivate disposable sample chamber - for Captivate magnetic yoke - set of 10 from Molecular Probes (Invitrogen)
Biology Products: